GLAUKOS CORP (GKOS) Stock News

Wondering what's happening in today's after-hours session?

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Mentions: MELI BJRI AXTI SEM ...

Consumer Sentiment Drops 10%, UnitedHealth Under Investigation: What's Driving Markets Friday?

All three major U.S. stock indices are down Friday as traders reacted to several sets of fresh data that raised concerns about the economic outlook. 

Mentions: GLOB SEI SPY ZM ...

Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition

Glaukos reported Q4 sales of $105.5 million, surpassing estimates, while EPS missed. Analysts see strong growth potential as the company expands its business model.

Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results

Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls

Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls

Mentions: EA COF NTAP DFS ...

Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

Glaukos Announces Participation in Upcoming Investor Conferences

Glaukos Announces Third Quarter 2024 Financial Results

Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa™, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety

Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting

Glaukos to Release Third Quarter 2024 Financial Results after Market Close on November 4